Details for New Drug Application (NDA): 088343
✉ Email this page to a colleague
NDA 088343 describes BROMANYL, which is a drug marketed by Alpharma Us Pharms and is included in one NDA. Additional details are available on the BROMANYL profile page.
The generic ingredient in BROMANYL is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
The generic ingredient in BROMANYL is bromodiphenhydramine hydrochloride; codeine phosphate. There are two drug master file entries for this compound. Additional details are available on the bromodiphenhydramine hydrochloride; codeine phosphate profile page.
Summary for 088343
| Tradename: | BROMANYL |
| Applicant: | Alpharma Us Pharms |
| Ingredient: | bromodiphenhydramine hydrochloride; codeine phosphate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SYRUP;ORAL | Strength | 12.5MG/5ML;10MG/5ML | ||||
| Approval Date: | Aug 15, 1984 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
